Gerresheimer AG (ETR:GXI – Get Free Report)’s share price dropped 0.7% on Wednesday . The company traded as low as €79.00 ($82.29) and last traded at €80.95 ($84.32). Approximately 166,777 shares changed hands during trading, an increase of 18% from the average daily volume of 140,925 shares. The stock had previously closed at €81.50 ($84.90).
Gerresheimer Stock Down 0.7 %
The firm has a market cap of $2.77 billion, a price-to-earnings ratio of 24.25, a PEG ratio of 0.82 and a beta of 0.94. The company has a quick ratio of 0.40, a current ratio of 0.80 and a debt-to-equity ratio of 87.94. The firm has a fifty day moving average price of €71.08 and a 200-day moving average price of €82.18.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Recommended Stories
- Five stocks we like better than Gerresheimer
- What is a Bond Market Holiday? How to Invest and Trade
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Transportation Stocks Investing
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.